Insights into resistance mechanisms against antibody-drug conjugates using large cancer cell panel profiling
European Journal of Cancer · 2026-11 · 248 · 117491
DOI: 10.1016/j.ejca.2026.117491 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von J. Melis und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Melis, J., Kluitmans, D., Smits, E., Kooijman, J., Roos, J. D., Lam, T., Aatsinki, S., Rytkönen, J., Drossaert-Smeets, M., & Benningshof, J. (2026). Insights into resistance mechanisms against antibody-drug conjugates using large cancer cell panel profiling. European Journal of Cancer, 248, 117491. https://doi.org/10.1016/j.ejca.2026.117491
Vancouver
Melis J, Kluitmans D, Smits E, Kooijman J, Roos JD, Lam T, et al. Insights into resistance mechanisms against antibody-drug conjugates using large cancer cell panel profiling. European Journal of Cancer. 2026;248:117491. doi:10.1016/j.ejca.2026.117491
BibTeX
@article{Melis2026,
author = {Melis, J. and Kluitmans, D. and Smits, E. and Kooijman, J. and Roos, J. De and Lam, T. and Aatsinki, S.M. and Rytkönen, J. and Drossaert-Smeets, M. and Benningshof, J.},
title = {Insights into resistance mechanisms against antibody-drug conjugates using large cancer cell panel profiling},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117491},
doi = {10.1016/j.ejca.2026.117491}
}
EUVIMED